iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant (BUCKiPAD)
Anxiety, Depression, Malignant Neoplasm

About this trial
This is an interventional supportive care trial for Anxiety
Eligibility Criteria
Inclusion Criteria:
- Adult patients undergoing treatment in the bone marrow transplant (BMT) unit on the 3rd floor of the James Cancer Hospital and Solove Research Institute
- Patients receiving reduced intensity chemotherapy for an allogeneic stem cell transplant
Exclusion Criteria:
Patients who lack the visual or motor skills necessary to use a tablet device like the Apple iPad
- Criteria for visual proficiency will be determined by asking the patient: do you have trouble reading a newspaper even with your glasses or contacts (if you wear them); if "yes", they will be excluded
- Criteria for motor skill proficiency will be determined by asking the patient: do you have any trouble using a television remote control; if "yes", they will be excluded
- Patients who do not speak English
Sites / Locations
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
No Intervention
GROUP A (participants provide own computer or tablet device)
GROUP B (Apple BuckiPad)
GROUP C (no intervention)
A member of the research personnel helps the participants install Netflix, Spotify, and Skype applications on their computers if they wish to do so. Participants will be given subscriptions to each application and usernames for access on days -5 to 10.
Participants receive an iPad for days -5 to 10. Participants also receive the BuckiPad manual for instructions on how to use the iPad and Netflix, Skype, and Spotify applications. Participants are also directed to the official Apple's iPad user's manual on their device and have questions answered by research personnel on day -5.
Participants do not receive an iPad for days -5 to 10.